Immunotherapy

Papers
(The H4-Index of Immunotherapy is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Imaging of brain metastases treated with immune checkpoint inhibitors122
Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) study38
Cost–Effectiveness Analysis of Serplulimab as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma32
Atezolizumab and Bevacizumab prior to liver transplantation in hepatic angiosarcoma mimicking hepatocellular carcinoma32
Real-World Outcomes with Immuno-Oncology Therapies in Advanced Melanoma: Final Results of the OPTIMIzE Registry Study27
Identifying risk factors and biomarkers for severe CIP in lung cancer patients– a retrospective case series study27
Simulating a virtual tumor board with large language models: a pilot study in NSCLC patients receiving immunotherapy23
Disrupting neuro-immune feedback loops: novel targets to amplify cancer immunotherapy20
Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor Pd-L1 Expression in Asia19
Postvaccination immune-mediated hepatitis: what do we really know?19
MicroRNA prognostic markers for immune checkpoint inhibitor success in urologic cancers18
Targeting PD-1/PD-L1 in Biliary Tract Cancer: Role and Available Data18
Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-15818
Pd-1, Pd-L1, Ido, Cd70 and Microsatellite Instability as Potential Targets to Prevent Immune Evasion in Sarcomas18
Diagnostic and therapeutic evaluation of Blomia tropicalis in patients with allergic rhinitis17
The role of bronchoscopic cryoimmunotherapy in non-small cell lung cancer: current evidence and future perspectives16
Therapeutic lymph node dissection with neoadjuvant immunotherapy for macroscopic melanoma – too much skin in the game?16
0.17133712768555